Better Therapeutics Inc. (BTTX)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Mar 31, 2025, 3:22 PM

Better Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	6.6M	6.2M	6.07M	15.74M	22.3M	29.68M	31.67M	40.57M	248.46K	2.12M	392.9K	123.00	-757
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.51K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	57.51M	57.51M	57.5M	n/a	n/a
Other Long-Term Assets	483K	483K	483K	488K	488K	487K	488K	548K	-5.17K	193K	-6.21K	-5.64K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	73K	1.23M	406K	210K	1.19M	2.45M	3.51M	4.68M	43.25K	1.74M	128.22K	340.00	n/a
Total Current Assets	7.34M	7.42M	8.44M	18.45M	23.49M	32.14M	35.18M	45.25M	291.71K	3.85M	521.12K	463.00	757.00
Property-Plant & Equipment	102K	115K	131K	121K	122K	115K	98K	82K	61.00	58K	73.00	89.00	n/a
Goodwill & Intangibles	2.79M	3.58M	3.75M	3.89M	4.12M	4.36M	4.53M	5.08M	5.11K	5.63M	6.14K	5.55K	n/a
Total Long-Term Assets	3.38M	4.18M	4.37M	4.5M	4.73M	4.97M	5.11M	5.71M	57.51M	5.88M	57.5M	5.64K	n/a
Total Assets	10.72M	11.6M	12.81M	22.94M	28.22M	37.1M	40.29M	50.96M	57.8M	9.73M	58.02M	6.39K	n/a
Account Payables	2.31M	2.98M	2.51M	3.04M	1.25M	1.09M	735K	1.52M	n/a	1.4M	649.00	514.00	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	4.92M	3.26M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	6.59M	5.69M	5.54M	4.53M	3.13M	1.78M	304K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	5.2M	n/a	n/a	n/a	n/a	n/a	3.21M	244.57K	n/a	67.68K	99.00	n/a
Total Current Liabilities	12.94M	13.87M	13.64M	13.49M	9.31M	6.14M	3.57M	4.73M	244.57K	2.68M	68.33K	613.00	n/a
Long-Term Debt	7.72M	8.52M	9M	10.35M	11.66M	12.91M	9.3M	9.51M	n/a	n/a	n/a	640.00	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.01M	27.73M	2.01M	-640	n/a
Total Long-Term Liabilities	7.72M	8.52M	9M	10.35M	11.66M	12.91M	9.3M	9.51M	2.01M	27.73M	2.01M	640.00	n/a
Total Liabilities	20.66M	22.39M	22.64M	23.84M	20.97M	19.05M	12.87M	14.24M	2.26M	30.41M	2.08M	13.14K	n/a
Total Debt	14.31M	14.21M	14.54M	14.88M	14.79M	14.69M	9.6M	9.51M	n/a	n/a	n/a	n/a	n/a
Common Stock	4K	3K	2K	2K	2K	2K	2K	2K	57.5M	1K	50.94M	1.00	n/a
Retained Earnings	-134.31M	-128.45M	-120.86M	-111.5M	-102.74M	-91.33M	-81.41M	-71.74M	-1.96M	-45.39M	-149.32K	-31.41K	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-57.52M	n/a	-50.97M	n/a	n/a
Shareholders Equity	-9.94M	-10.79M	-9.83M	-899K	7.25M	18.05M	27.43M	36.72M	55.54M	-20.68M	55.94M	-6.76K	-605
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	57.51M	57.51M	57.5M	n/a	1.51K